JP3277436B2 - Mutagen detection method using luminescent gene - Google Patents
Mutagen detection method using luminescent geneInfo
- Publication number
- JP3277436B2 JP3277436B2 JP22965994A JP22965994A JP3277436B2 JP 3277436 B2 JP3277436 B2 JP 3277436B2 JP 22965994 A JP22965994 A JP 22965994A JP 22965994 A JP22965994 A JP 22965994A JP 3277436 B2 JP3277436 B2 JP 3277436B2
- Authority
- JP
- Japan
- Prior art keywords
- gene
- sos
- test sample
- added
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、発光方式の短期変異原
検出法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a luminescent short-term mutagen detection method.
【0002】[0002]
【従来の技術】現在、発ガン性物質の短期スクリーニン
グ法として微生物を用いた突然変異試験法が数多く報告
されている。その中でも復帰突然変異試験法であるAm
esテストが最も広く利用されている。しかし、この試
験法は測定までに約3日を要し、無菌操作を必要とする
など問題点を有している。最近、突然変異の誘発性を検
出するAmes法とは異なり、DNAの損傷性を検出す
る短期変異原検出法(umuテスト、SOSクロモテス
ト)が報告された(小田、中村等、"Evalution of the
new system (umu-test) for the detection of environ
mental mutagensand carcinogens"、Mutation Researc
h, 147(1985)219-229 、特公平4−12118)。2. Description of the Related Art At present, many mutation test methods using microorganisms have been reported as short-term screening methods for carcinogenic substances. Among them, the reverse mutation test method, Am
The es test is the most widely used. However, this test method has a problem that it takes about 3 days to measure and requires aseptic operation. Recently, a short-term mutagen detection method (umu test, SOS chromo test) for detecting DNA damage, unlike the Ames method for detecting mutagenicity, was reported (Oda, Nakamura et al., "Evalution of the
new system (umu-test) for the detection of environ
mental mutagensand carcinogens ", Mutation Researc
h, 147 (1985) 219-229, Japanese Patent Publication No. 4-12118).
【0003】これらの方法は、DNA損傷時に誘発され
るSOS反応を、SOS遺伝子の一つであるumuD,
C遺伝子又はsfiA遺伝子の下流にlacZ遺伝子を
連結することによりβ−ガラクトシダーゼの発現量とし
て測定し、DNA損傷性、変異原性を検出する方法であ
る。より具体的には、上記遺伝子を導入したサルモネラ
菌(umuテスト)、大腸菌(SOSクロモテスト)を
被検物質の存在下で培養した後、トルエン又はクロロホ
ルムとドデシルベンゼンスルホン酸ナトリウムのような
スルホン酸塩型界面活性剤水溶液を加え、細胞壁破壊処
理を行う。[0003] In these methods, the SOS response induced at the time of DNA damage is determined by using one of the SOS genes, umuD,
This is a method for detecting DNA damage and mutagenicity by measuring the expression level of β-galactosidase by ligating the lacZ gene downstream of the C gene or sfiA gene. More specifically, after culturing Salmonella (Umu test) and Escherichia coli (SOS Chromotest) into which the above-described genes have been introduced in the presence of a test substance, toluene or chloroform and a sulfonate such as sodium dodecylbenzenesulfonate are used. An aqueous solution of a surfactant is added to perform cell wall destruction treatment.
【0004】次いでβ−ガラクトシダーゼ活性を測定す
る目的で、2−ニトロフェニル−β−D−ガラクトピラ
ノシド水溶液を加え、28℃で酵素反応を行い、数十分
後、炭酸ナトリウムで反応を停止する。酵素反応液の光
学濃度を二波長(420,550nm) で計測し、ミラー
法(Miller.J.H., Experiments in molecular genetic
s, Cold Spring Harbor Laboratory, 1972)に基づいて
β−ガラクトシダーゼ活性を算出する。Then, for the purpose of measuring the β-galactosidase activity, an aqueous solution of 2-nitrophenyl-β-D-galactopyranoside is added, the enzyme reaction is carried out at 28 ° C., and after several tens minutes, the reaction is stopped with sodium carbonate. I do. The optical density of the enzyme reaction solution was measured at two wavelengths (420, 550 nm) and the mirror method (Miller. JH, Experiments in molecular genetic
s, Cold Spring Harbor Laboratory, 1972) to calculate β-galactosidase activity.
【0005】上記umuテスト、SOSクロモテスト
は、Ames法に比べかなり迅速に検出できるものの比
色検出であるため検出感度が低く、検出時間も依然とし
て7〜8時間程度を要する。特に、これらのテストは、
ニトロアレーンおよび多環芳香族化合物に対する検出感
度が低く、大きな問題となっている。The above-mentioned umu test and SOS chromo test can be detected much more quickly than the Ames method, but they are colorimetric detections, so their detection sensitivity is low, and the detection time still requires about 7 to 8 hours. In particular, these tests
The detection sensitivity for nitroarenes and polycyclic aromatic compounds is low, which is a major problem.
【0006】[0006]
【発明が解決しようとする課題】従って本発明は、検出
感度が高く、且つ検出時間の短い、SOS遺伝子のDN
A損傷感受性を利用した変異原性物質の検出方法を提供
しようとするものである。SUMMARY OF THE INVENTION Accordingly, the present invention provides a SOS gene DN having a high detection sensitivity and a short detection time.
It is an object of the present invention to provide a method for detecting a mutagenic substance using sensitivity to A damage.
【0007】[0007]
【課題を解決するための手段】本発明者らは、上記の課
題を解決すべく種々検討した結果、DNAの損傷に対し
て感受性のSOS遺伝子の下流にルシフェラーゼ活性を
発現する遺伝子を配置した組換え遺伝子により形質転換
された微生物を変異原性物質を含有する培地中で培養す
れば、該SOS遺伝子の発現と同時にルシフェラーゼ活
性を有する遺伝子も発現され、これによって発生した光
を測定することにより短時間に高感度で変異原性物質を
検出又は測定することができることを見出し、本発明を
完成した。Means for Solving the Problems The present inventors have conducted various studies to solve the above-mentioned problems, and as a result, have found that a group in which a gene that expresses luciferase activity is arranged downstream of an SOS gene that is sensitive to DNA damage. When the microorganism transformed with the transgene is cultured in a medium containing a mutagenic substance, a gene having luciferase activity is also expressed at the same time as the expression of the SOS gene, and the light generated thereby is measured. The present inventors have found that a mutagenic substance can be detected or measured with high sensitivity in a short time, and completed the present invention.
【0008】従って本発明は、DNA損傷時に発現され
るSOS遺伝子と該遺伝子の下流に配置されたルシフェ
ラーゼ活性を有する遺伝子とを含んで成る組換え遺伝子
を提供する。本発明はまた、前記遺伝子により形質転換
された宿主微生物を提供する。本発明はさらに、前記宿
主微生物を、被験試料を含有する培地中で培養し、次に
前記ルシフェラーゼ活性を発現する遺伝子の発現による
発光を測定する、ことを特徴とする被験試料中の変異原
性物質の存否の決定又は存在量の測定を行うための方法
を提供する。Accordingly, the present invention provides a recombinant gene comprising an SOS gene expressed upon DNA damage and a gene having luciferase activity arranged downstream of the SOS gene. The present invention also provides a host microorganism transformed with the gene. The present invention further comprises culturing the host microorganism in a medium containing a test sample, and then measuring the luminescence due to the expression of the gene expressing the luciferase activity, wherein the mutagenicity in the test sample is measured. A method is provided for determining the presence or absence of a substance or measuring the amount of a substance.
【0009】本発明においては、ルシフェラーゼ活性を
発現する遺伝子をDNAの損傷に依存して発現させるた
めに、その発現制御手段としてSOS遺伝子を利用す
る。従って、SOS遺伝子はDNA損傷時に発現される
ものであればよく、SOSボックスと称する制御部分を
含有するものであればよい。従って、本発明において
「DNA損傷時に発現されるSOS遺伝子」とは、前記
SOSボックスと称される制御部位を含有するものを意
味し、SOSボックス自体でもよく、またこれを含有す
る任意のDNA断片であってもよい。In the present invention, in order to express a gene that expresses luciferase activity depending on DNA damage, the SOS gene is used as an expression control means. Therefore, the SOS gene only needs to be expressed at the time of DNA damage, and only needs to contain a control portion called an SOS box. Therefore, in the present invention, the “SOS gene expressed upon DNA damage” means a gene containing a control site called the SOS box, and may be the SOS box itself, or any DNA fragment containing the same. It may be.
【0010】SOS遺伝子としては、umu遺伝子、例
えばumuC遺伝子及びumuD遺伝子、並びにsfi
A遺伝子等が挙げられるがこれに限定されない。これら
の遺伝子の内、umuC遺伝子及びumuD遺伝子はPr
o. Natl. Acad. Sci. USA, Vol. 82, 4336-4340 (1985)
に記載されており、これらの記載に基いて容易に入手す
ることができる。また、umuD遺伝子とlacZ遺伝
子との融合遺伝子を含有するプラスミドpSK1002
はH.Shinagawa ら、Gene, 23, 167(1983) に記載されて
おり、このプラスミドからumuD遺伝子を容易に入手
することができる。[0010] SOS genes include umu genes, such as the umuC and umuD genes, and the sfi gene.
A gene and the like are included, but not limited thereto. Of these genes, the umuC and umuD genes are Pr
o. Natl. Acad. Sci. USA, Vol. 82, 4336-4340 (1985)
And can be easily obtained based on these descriptions. Also, a plasmid pSK1002 containing a fusion gene of the umuD gene and the lacZ gene.
Is described in H. Shinagawa et al., Gene, 23, 167 (1983), and the umuD gene can be easily obtained from this plasmid.
【0011】ルシフェラーゼ活性を発現する遺伝子とし
ては種々の由来のものを使用することができるが、例え
ば、北米産ホタル(Photinus pyrali
s)由来のルシフェラーゼ遺伝子(luc遺伝子)を挿
入したベクターがピッカジーン (TM)カセットベクターと
して東洋インキ製造(株)から販売されており、これを
用いるのが便利である。[0011] As a gene expressing luciferase activity,
Can be of various origins.
For example, North American fireflies (Photinus pyrali
s) -Derived luciferase gene (luc gene)
The vector entered is Picker Gene (TM)Cassette vector and
Sold by Toyo Ink Manufacturing Co., Ltd.
Convenient to use.
【0012】宿主微生物としては、それらのDNAが変
異原性物質により損傷された際にSOS遺伝子を発現さ
せることができる微生物、すなわちSOS機能を有する
微生物であればよく、例えば大腸菌(Escheric
hia coli)、例えばそのCSH26株、サルモ
ネラ菌(Salmonella typhimuriu
m)、例えばそのTA1535株、1538株等、バシ
ルス(Bacillus)、例えばバシルス・ズブチリ
ス(B. subtilis)等が挙げられる。The host microorganism may be any microorganism that can express the SOS gene when its DNA is damaged by a mutagen, that is, a microorganism having an SOS function. For example, Escherichia coli ( Escheric)
hia coli), for example the CSH26 strain, Salmonella (Salmonella typhimuriu
m ), for example, the TA1535 strain, 1538 strain, etc., and Bacillus , for example, B. subtilis, and the like.
【0013】SOS遺伝子と、ルシフェラーゼ活性を発
現する遺伝子とを含んで成る組換え遺伝子は、SOS遺
伝子のSOSボックスを少なくとも含有するDNA断片
の該SOSボックスより下流に、ルシフェラーゼ活性を
発現する遺伝子を連結することにより作製することがで
きる。この連結は、DNAリガーゼを用いて常法に従っ
て行うことができる。この組換え遺伝子を宿主微生物に
導入するためには、該組換え遺伝子はベクター中に存在
する必要があり、これらのベクターとしては、例えばp
BR系プラスミド、pUC系プラスミド等を利用するこ
とができる。A recombinant gene comprising the SOS gene and a gene expressing luciferase activity is linked to a gene expressing luciferase activity downstream of the SOS box of a DNA fragment containing at least the SOS box of the SOS gene. By doing so, it can be manufactured. This ligation can be performed using DNA ligase according to a conventional method. In order to introduce this recombinant gene into a host microorganism, the recombinant gene must be present in a vector.
BR-based plasmids, pUC-based plasmids and the like can be used.
【0014】発現ベクターにより宿主微生物を形質転換
するには、微生物、例えば細菌の形質転換に用いられる
常法によればよい。本発明に従って、被験試料中の変異
原性物質を検出又は測定するには、被験試料を培地に混
合した後、この培地中で前記形質転換された宿主微生物
を培養する。培養は通常1〜3時間行われる。次に培養
菌体を集め、細胞壁を破壊して発現生成物、即ちルシフ
ェラーゼを細胞から放出させる。この細胞破壊は、常法
に従って、例えば細胞壁溶解剤、例えば界面活性剤であ
るTritonX,SDS等を用いて、あるいは超音波
処理等の機械的処理により容易に行うことができる。Transformation of a host microorganism with an expression vector may be performed by a conventional method used for transforming a microorganism, for example, a bacterium. According to the present invention, to detect or measure a mutagenic substance in a test sample, the test sample is mixed with a medium, and the transformed host microorganism is cultured in the medium. The culture is usually performed for 1 to 3 hours. The cultured cells are then collected and the cell wall is disrupted to release the expression product, luciferase, from the cells. This cell destruction can be easily carried out according to a conventional method, for example, using a cell wall lysing agent, for example, Triton X, SDS, which is a surfactant, or by mechanical treatment such as ultrasonic treatment.
【0015】次に、この細胞溶解物を、例えば遠心分離
することにより、ルシフェラーゼを含有する上清を得、
これを発光処理にかける。この発光処理は、基質(例え
ばルシフェリン)、補酵素等の必要な成分を添加するこ
とにより行われる。こうして生じた光は、常法に従って
検出することができる。本発明の方法によれば、すべて
の変異原性物質を検出の対象とすることができる。変異
原性物質は、最終的には溶液として培地に導入される
が、気体や固体でも培地に溶解するものであれば測定す
ることができる。Next, the cell lysate is centrifuged, for example, to obtain a luciferase-containing supernatant.
This is subjected to light emission processing. This luminescence treatment is performed by adding necessary components such as a substrate (for example, luciferin) and a coenzyme. The light thus generated can be detected according to a conventional method. According to the method of the present invention, all mutagenic substances can be detected. The mutagenic substance is finally introduced into the medium as a solution, but it can be measured even if it is a gas or a solid that can be dissolved in the medium.
【0016】[0016]
【発明の効果】従来のAmesテストでは測定するのに
十分な発色を得るために所定の時間(少なくとも30分
以上)を要するのに比し、本発明では測定するのに十分
な発光を瞬時に得る、等の点から、本発明の方法によれ
ば、検出時間が大幅に短縮される。また、本発明法は、
発光検出によるため、発光測定に必要なサンプルの容積
が少なくてすむため、従来の比色検出に比べて絶対量換
算で約100倍高い感度で変異原性物質を検出すること
ができる。さらに、発光検出によるため、測定のダイナ
ミックレンジが広がり、変異原性物質の最少検出濃度を
少なくとも4倍以上低濃度側で高感度に検出することが
できる。特にニトロアレーン、多環芳香族化合物につい
ては、それらの最少検出濃度を約10倍低濃度側で高感
度に検出することができる。According to the conventional Ames test, it takes a predetermined time (at least 30 minutes or more) to obtain sufficient color development for measurement, whereas in the present invention, sufficient light emission for measurement is instantaneously emitted. In terms of obtaining and the like, the method of the present invention greatly reduces the detection time. Also, the method of the present invention,
Since luminescence detection is used, the volume of the sample required for luminescence measurement can be reduced, so that a mutagenic substance can be detected with a sensitivity about 100 times higher in terms of absolute amount than conventional colorimetric detection. Furthermore, since the detection is based on luminescence, the dynamic range of the measurement is widened, and the minimum detection concentration of the mutagenic substance can be detected at least four times or more at a low concentration side with high sensitivity. In particular, nitroarenes and polycyclic aromatic compounds can be detected with high sensitivity at a minimum concentration of about 10 times lower than the minimum detection concentration.
【0017】[0017]
【実施例】次に実施例により本発明をさらに具体的に説
明する。実施例1. 大腸菌での測定 下記に示す組み換え体プラスミドの構築方法では、um
uC遺伝子とルシフェラーゼ遺伝子(以下、lucと省
略)との融合遺伝子によるumuC−luc融合蛋白質
を生産させるような構築方法をとっているが、ルシフェ
ラーゼ活性を有するポリペプチドをコードする遺伝子が
SOS遺伝子群の制御下にあれば必ずしも融合蛋白質を
生産させるような構築方法でなくてもよい。Next, the present invention will be described more specifically with reference to examples. Embodiment 1 FIG. Measurement in Escherichia coli
A construction method is employed in which a umuC-luc fusion protein is produced by a fusion gene of a uC gene and a luciferase gene (hereinafter abbreviated as luc), but a gene encoding a polypeptide having luciferase activity is a member of the SOS gene group. As long as it is under control, the construction method does not necessarily need to be such that a fusion protein is produced.
【0018】SOS遺伝子として、umuD,C−la
cZ融合遺伝子を備えたプラスミドpSK1002「H.
Shinagawa, T.Kato, T.Ise, K.Makino, A.Nakata, Gen
e, 23, 167(1983) 」のumu遺伝子を利用した。ルシ
フェラーゼ活性を有するポリペプチドをコード遺伝子と
して、東洋インキ製造(株)製のピッカジーンTMカセッ
トベクター上の北米産ホタル(Photinus py
ralis)由来のluc遺伝子を利用した。As the SOS gene, umuD, C-la
Plasmid pSK1002 with the cZ fusion gene "H.
Shinagawa, T.Kato, T.Ise, K.Makino, A.Nakata,Gen
e,twenty three, 167 (1983) ". Rushi
A polypeptide having ferase activity as an encoding gene;
Picka Gene manufactured by Toyo Ink Manufacturing Co., Ltd.TMCassette
North American fireflies (Photoninus py)
lucis) (lucis).
【0019】導入する細菌として、大腸菌(CSH26 「Mi
ller, J.H., Experiments in Molecular Genetics, Col
d Spring Harbor Laboratory, 1972」:F - ara del(la
c-pro)thi)、サルモネラ菌 (TAl535「Ames, B.N., J.Mc
Cann, E.Yamasaki, MutationRes., 31, 347, (1975)
」:hisG46, Δgal, Δchl, Δbio, ΔuvrB, rf
a - 、SJ10002 :r - ,m+ ) を利用した。As a bacterium to be introduced, Escherichia coli (CSH26 "Mi
ller, J.H., Experiments in Molecular Genetics, Col
d Spring Harbor Laboratory, 1972 ": F-ara del (la
c-pro) thi), Salmonella (TAl535 `` Ames, B.N., J. Mc
Cann, E. Yamasaki,MutationRes.,31, 347, (1975)
: HisG46, Δgal, Δchl, Δbio, ΔuvrB, rf
a -, SJ10002: r-, m+) Was used.
【0020】発光測定で使用した発光基質、細胞溶解剤
は、東洋インキ製(株)の発光キット(ピッカジー
ンTM)を用いた。発光基質の組成は、20mM Tricine,
1.07mM (MgCO3)4Mg(OH)2・5H2O, 2.67mM MgSO4, 0.1mM
EDTA, 33.3mM DTT, 270 μM CoenzymeA, 470 μM luc
iferin, 530 μM ATP。細胞溶解剤の組成は、25mM Tri
s-phosphate(pH 7.8), 2mM DTT, 2mM 1,2-diaminocyclo
hexane-N, N, N, N-tetraacetic acid, 10% glycerol,
1% Triton X-100 。発光測定装置は、浜松フォトニク
ス(株)製のユニバーサルフォトンカウンティングシス
テムを使用した。As a luminescent substrate and a cell lysing agent used in the luminescence measurement, a luminescence kit (Picagene ™ ) manufactured by Toyo Ink Co., Ltd. was used. The composition of the luminescent substrate was 20 mM Tricine,
1.07mM (MgCO 3 ) 4 Mg (OH) 2・ 5H 2 O, 2.67mM MgSO 4 , 0.1mM
EDTA, 33.3 mM DTT, 270 μM CoenzymeA, 470 μM luc
iferin, 530 μM ATP. The composition of the cell lysing agent is 25 mM Tri
s-phosphate (pH 7.8), 2mM DTT, 2mM 1,2-diaminocyclo
hexane-N, N, N, N-tetraacetic acid, 10% glycerol,
1% Triton X-100. As the luminescence measuring device, a universal photon counting system manufactured by Hamamatsu Photonics Co., Ltd. was used.
【0021】pSK1002ベクターを含む大腸菌CS
H26をアンピシリンを含むLB培地(Bactoトリ
プトン1%、Bacto酵母エキス0.5%、NaCl
1%)で培養後、アルカリ−SDS法「Birnboim, H.
C., Doly, J., Nucl.Acids Res.,11, 1513(1979)」によ
って、pSK1002ベクターを大量に調製した。制限
酵素HindIII ,AvaIでベクターを切断し、um
u遺伝子を含む約7.2KbのDNA断片(A)を切り出
した。断片(A)をAlkaline Phospha
tase(E.coli C75)を用い、脱リン酸化
処理した。E. coli CS containing pSK1002 vector
H26 containing LB medium containing ampicillin (Bacto tryptone 1%, Bacto yeast extract 0.5%, NaCl
1%), alkali-SDS method "Birnboim, H. et al.
C., Doly, J., Nucl . Acids Res ., 11 , 1513 (1979) ", prepared a large amount of the pSK1002 vector. The vector was cut with restriction enzymes HindIII and AvaI and um
A DNA fragment (A) of about 7.2 Kb containing the u gene was cut out. Fragment (A) was converted to Alkaline Phospha.
Dephosphorylation treatment was carried out using Tase (E. coli C75).
【0022】ホタル由来のluc遺伝子を含むベクター
を大腸菌JM109「Messing, J.,Gene, 33, 119(198
5) 」に形質転換した。形質転換した大腸菌をアンピシ
リンを含むLB培地で培養後、アルカリ−SDS法でl
ucを含むベクターを大量に調製した。制限酵素Hin
dIII ,StuIでベクターを切断し、luc遺伝子を
含む約1.7KbのDNA断片(B)を切り出した。The vector containing the firefly-derived luc gene was transformed into Escherichia coli JM109 "Messing, J., Gene , 33 , 119 (198
5) was transformed. The transformed Escherichia coli was cultured in an LB medium containing ampicillin, and then subjected to alkaline-SDS method.
The vector containing uc was prepared in large quantities. Restriction enzyme Hin
The vector was cut with dIII and StuI to cut out a DNA fragment (B) of about 1.7 Kb containing the luc gene.
【0023】断片(A)と断片(B)をDNA Lig
ation Kit(宝酒造)を用い、ライゲーション
後、制限酵素StuIで切断した。その後、DNA B
lunting Kit(宝酒造)を用い、平滑末端化
処理を行った後、DNA Ligation Kitに
てセルフライゲーションを行い、発現ベクターを構築し
た。umuC−luc融合蛋白質を生産させるため、上
記構築した発現ベクターを制限酵素HindIII で切断
した。DNA Blunting Kitにて平滑末端
化処理を行った後、DNA Ligation Kit
にてセルフライゲーションを行い、umuC−luc融
合蛋白質生産発光ベクターを構築した。Fragment (A) and fragment (B) were combined with DNA Lig
Using Ligation Kit (Takara Shuzo), the ligation was followed by digestion with the restriction enzyme StuI. Then, DNA B
After performing blunt-end treatment using a lunting kit (Takara Shuzo), self-ligation was performed with a DNA Ligation Kit to construct an expression vector. In order to produce the umuC-luc fusion protein, the expression vector constructed above was cut with the restriction enzyme HindIII. After performing blunt-end treatment with DNA Blunting Kit, DNA Ligation Kit
Was used to construct a luminescent vector for producing an umuC-luc fusion protein.
【0024】CSH26をLB培地で一夜培養した。L
B培地に、1/100容量の前記培養液を加え、600
nmにおける濁度(OD600)が約0.4になるまで培養し
た。培養液5mlを遠心分離し、沈殿画分(菌体)を5ml
の30mM CaCl2 水溶液に懸濁し、45分間氷中に
放置した。再度遠心分離を行い、菌体を0.4mlの30
mM CaCl2 に懸濁した。CSH26 was cultured overnight in LB medium. L
1/100 volume of the above culture solution was added to the B medium,
The cells were cultured until the turbidity (OD 600 ) at nm became about 0.4. 5 ml of the culture solution is centrifuged, and 5 ml of the precipitated fraction (cells) is centrifuged.
Was suspended in a 30 mM aqueous solution of CaCl 2 and left on ice for 45 minutes. Centrifugation was performed again, and the cells were clarified in 0.4 ml of 30 ml.
Suspended in mM CaCl 2 .
【0025】このようにして調製したCSH26のコン
ピテントセル100μlに、前記発光ベクター約200
ngを加え、30分間氷中に放置した。2分間42℃で処
理した後、室温にて5分間放置した。LB培地1mlを加
え、37℃で1時間インキュベートした。この液をアン
ピシリン50μg/mlを含むLBプレートに播種した。To 100 μl of the competent cells of CSH26 thus prepared, about 200
ng was added and left on ice for 30 minutes. After treatment at 42 ° C. for 2 minutes, the mixture was left at room temperature for 5 minutes. 1 ml of LB medium was added and incubated at 37 ° C. for 1 hour. This solution was seeded on an LB plate containing 50 μg / ml of ampicillin.
【0026】CSH26の発光ベクター形質転換体をア
ンピシリン20μg/mlを含むLB培地で一夜培養し
た。この培養液をLB培地に1/50容量植菌し、37
℃で対数増殖期まで(OD600 =0.2〜0.3)培養
した。この菌液を29μlずつ試験管に分注し、それぞ
れに所定濃度の2−(2−Furyl)−3−(5−n
itro−2−furyl)−acrylamide
(以下AF−2と略記)を1μl加えて37℃で2時間
インキュベートした。The CSH26 luminescent vector transformant was cultured overnight in an LB medium containing 20 μg / ml of ampicillin. This culture solution was inoculated into LB medium at 1/50 volume, and
℃ up to the logarithmic growth phase (OD 600 = 0.2~0.3) were cultured. This bacterial solution was dispensed into test tubes in an amount of 29 μl each, and 2- (2-Furyl) -3- (5-n
intro-2-furyl) -acrylamide
(Hereinafter abbreviated as AF-2) (1 μl), and the mixture was incubated at 37 ° C. for 2 hours.
【0027】この菌液を遠心し、沈澱画分(菌体)に細
胞溶解剤20μlを加え懸濁した。懸濁液を超音波破砕
装置(東湘電機)を用い30秒間×5回処理し、遠心し
た。上清画分10μlに発光基質100μlを加え、発
光を測定した。測定は、8.192秒(2ミリ秒×40
96回)間のフォトン数をカウントし、ルシフェラーゼ
活性を求めた。結果を図1に示した。This bacterial solution was centrifuged, and 20 μl of a cell lysing agent was added to the precipitated fraction (cells) and suspended. The suspension was treated 5 times for 30 seconds using an ultrasonic crusher (Tosho Denki) and centrifuged. 100 μl of a luminescent substrate was added to 10 μl of the supernatant fraction, and luminescence was measured. The measurement was performed for 8.192 seconds (2 milliseconds × 40
The number of photons during 96) was counted, and the luciferase activity was determined. The results are shown in FIG.
【0028】実施例2. サルモネラ菌(TA153
5)での測定 実施例1と同様な方法でSJ10002のコンピテント
セルを作製した。TA1535をそれぞれLB培地で一
夜培養した。LB培地に、1/100容量の前記培養液
を加え、600nmにおける濁度(OD600)が約0.4に
なるまで培養した。培養液5mlを遠心分離し、沈澱画分
(菌体)を5mlの10mM CaCl2 ,10mM MnC
l2 ,10mM MgCl2 水溶液に懸濁し、45分間氷
中に放置した。再度遠心分離を行い、菌体を0.4mlの
10mM CaCl2 ,10mM MnCl2 ,10mM M
gCl2 水溶液に懸濁し、TA1535のコンピテント
セルを調製した。[0028]Embodiment 2. FIG. Salmonella (TA153
Measurement in 5) Competent of SJ10002 in the same manner as in Example 1.
A cell was prepared. Each of TA1535 in LB medium
Cultured overnight. 1/100 volume of the above culture solution in LB medium
And the turbidity at 600 nm (OD600) To about 0.4
Cultured until 5 ml of the culture solution is centrifuged and the precipitate fraction
(Bacteria) in 5 ml of 10 mM CaClTwo , 10 mM MnC
lTwo , 10 mM MgClTwo Suspend in aqueous solution and ice for 45 minutes
Left inside. Perform centrifugation again, and
10 mM CaClTwo , 10 mM MnClTwo , 10mM
gClTwo Suspend in aqueous solution and compete with TA1535
A cell was prepared.
【0029】SJ10002のコンピテントセル100
μlに、発光ベクター約200ng(実施例1において作
製したもの)を加え、30分間氷中に放置した。2分間
42℃で処理した後、室温にて5分間放置した。LB培
地1mlを加え、37℃で1時間インキュベートした。こ
の液をアンピシリン50μg/mlを含むLBプレートに
播種した。SJ10002に導入した発光ベクターをア
ルカリ−SDS法で調製し、前記と同様な方法でTA1
535への形質転換を行った。Competent cell 100 of SJ10002
About 200 ng of the luminescent vector (prepared in Example 1) was added to μl, and left on ice for 30 minutes. After treatment at 42 ° C. for 2 minutes, the mixture was left at room temperature for 5 minutes. 1 ml of LB medium was added and incubated at 37 ° C. for 1 hour. This solution was seeded on an LB plate containing 50 μg / ml of ampicillin. The luminescent vector introduced into SJ10002 was prepared by the alkaline-SDS method, and TA1 was prepared in the same manner as described above.
Transformation into 535 was performed.
【0030】TA1535の発光ベクター形質転換体を
用い、実施例1と同様な方法(LB培地の代わりにTG
A培地(トリプトン1%、食塩0.5%、グルコース
0.2%、アンピシリン20μg/ml)を用いた)でA
F−2による発光測定を行った。結果を図2に示した。
以下に示す比較例は、本発明と従来法の感度比較を行う
ために実施した。Using a luminescent vector transformant of TA1535, the same method as in Example 1 (TG instead of LB medium) was used.
A medium (using 1% tryptone, 0.5% salt, 0.2% glucose, 20 μg / ml ampicillin) in A medium
The luminescence measurement by F-2 was performed. The results are shown in FIG.
The comparative examples shown below were performed to compare the sensitivity of the present invention with that of the conventional method.
【0031】比較例1.プラスミドpSK1002が導
入された大腸菌(CSH26/pSK1002)を用い
た。0.1mol /lリン酸カリウム緩衝液(pH7.0)
11に0.75g塩化カリウム、0.246g硫酸マグ
ネシウム、0.05 mol/lの2−メルカプトエタノー
ル2mlを加え溶解し、Z−Bufferを調製した。 Comparative Example 1 Escherichia coli (CSH26 / pSK1002) into which plasmid pSK1002 was introduced was used. 0.1 mol / l potassium phosphate buffer (pH 7.0)
Then, 0.75 g of potassium chloride, 0.246 g of magnesium sulfate and 2 ml of 0.05 mol / l 2-mercaptoethanol were added to and dissolved in 11 to prepare a Z-Buffer.
【0032】CSH26/pSK1002を、アンピシ
リン20μg/mlを含むLB培地で一夜培養した。この
培養液を同じ培地に1/50容量植菌し、37℃で対数
増殖期まで(OD600 =0.2〜0.3)培養した。こ
の菌液を2.9mlずつ試験管に分注し、それぞれに所定
濃度のAF−2を0.1ml加えて37℃で2時間インキ
ュベートした。この菌液0.2mlに、Z−Buffer
l.8ml、0.1%SDS50μl、クロロホルム10
μlを加え、5秒間攪拌した。次に、0.1Mリン酸緩
衝液(pH7.0)に溶解した4mg/mlo−ニトロフェニ
ル−β−D−ガラクトピラノシド(ONPG)水溶液を
0.4ml加え、28℃で10分間反応させた後、1mol
/l炭酸ナトリウム溶液を1ml加え反応を停止した。そ
して、直ちに420nmにおける吸光度を測定した。結果
を図1に示した。CSH26 / pSK1002 was cultured overnight in an LB medium containing 20 μg / ml of ampicillin. This culture was inoculated into the same medium at 1/50 volume and cultured at 37 ° C. until the logarithmic growth phase (OD 600 = 0.2-0.3). 2.9 ml of this bacterial solution was dispensed into test tubes, and 0.1 ml of a predetermined concentration of AF-2 was added to each, followed by incubation at 37 ° C. for 2 hours. To 0.2 ml of this bacterial solution, add Z-Buffer
l. 8 ml, 50% of 0.1% SDS, chloroform 10
μl was added and stirred for 5 seconds. Next, 0.4 ml of a 4 mg / ml aqueous solution of 4-nitrophenyl-β-D-galactopyranoside (ONPG) dissolved in 0.1 M phosphate buffer (pH 7.0) was added, and the mixture was reacted at 28 ° C. for 10 minutes. 1mol
The reaction was stopped by adding 1 ml of a 1 / l sodium carbonate solution. Then, the absorbance at 420 nm was immediately measured. The results are shown in FIG.
【0033】比較例2.プラスミドpSK1002が導
入されたサルモネラ菌(TA1535/pSK100
2)を用いた。TA1535/pSK1002を用い、
比較例1と同様な方法(LB培地の代わりにTGA培地
(トリプトン1%、食塩0.5%、グルコース0.2
%、アンピシリン20μg/ml)を用いた)でAF−2
により、誘導されるβ−ガラクトシダーゼ活性の測定を
行った。結果を図2に示した。 Comparative Example 2 Salmonella harboring plasmid pSK1002 (TA1535 / pSK100
2) was used. Using TA1535 / pSK1002,
A method similar to that of Comparative Example 1 (TGA medium (1% tryptone, 0.5% salt, 0.2% glucose)
%, 20 μg / ml ampicillin).
Was used to measure the induced β-galactosidase activity. The results are shown in FIG.
【0034】図1及び2が示すように、発光遺伝子を有
する組み換え体プラスミドをCSH26に導入した菌株
では、AF−2約1ngから100ng程度まで良好なdo
se−response曲線を与えた。発光遺伝子を有
する組み換え体プラスミドをTA1535に導入した菌
株では、AF−2約0.1ngから1ng程度まで良好なd
ose−response曲線を与えた。従来法(比較
例)の結果と比較すると、本発明の方法の方が、CSH
26,TA1535両菌株ともに感度面で約100倍優
れていた。As shown in FIGS. 1 and 2, in a strain in which a recombinant plasmid having a luminescent gene was introduced into CSH26, good doF was obtained from about 1 ng to about 100 ng of AF-2.
A se-response curve was given. In a strain in which a recombinant plasmid having a luminescent gene was introduced into TA1535, AF-2 exhibited a good d from about 0.1 ng to about 1 ng.
An o-response curve was given. Compared with the results of the conventional method (Comparative Example), the method of the present invention shows that CSH
Both strains 26 and TA1535 were about 100 times better in sensitivity.
【0035】実施例3 サルモネラ菌(TA1535)
での測定 代謝活性化酵素 ラットの肝臓から得られ、フェノバルビタールと5,6
−ベンゾフラボンで処理されたS9画分(オリエンタル
酵母(株)製)を用い、これに補助因子としてCofa
ctor−I(オリエンタル酵母(株)製)を混合した
S9ミックスを用いた。 Example 3 Salmonella (TA1535)
Obtained from the liver of measuring metabolic activation enzyme rats with phenobarbital and 5,6
Benzoflavone-treated S9 fraction (manufactured by Oriental Yeast Co., Ltd.)
An S9 mix mixed with ctor-I (manufactured by Oriental Yeast Co., Ltd.) was used.
【0036】被験試料 AF−2,4−ニトロキノリン1−オキサイド(以下4
NQOと略す)、1−ニトロピレン(以下1−NPと略
す)、2−アミノアントラセン(以下2−AAと略
す)、ベンゾ [a] ピレン(以下BaPと略す)を用い
た。実施例2で得たTA1535の発光ベクター形質転
換体をTGA培地で一夜37℃で培養した。この培養液
をTGA培地に1/50容量植菌し、37℃で1.5時
間培養した。この培養液をOD600 =0.1になるよう
にTGA培地で希釈した。この希釈培養液を1.45ml
ずつ試験管に分注し、それぞれに所定濃度の被験試料5
0μl加え37℃で2時間培養した。代謝活性化酵素を
必要とする場合は、希釈培養液1.2mlにS9ミックス
0.25ml、被験試料50μlを加え、37℃で2時間
培養した。 Test sample AF-2,4-nitroquinoline 1-oxide (hereinafter referred to as 4)
NQO), 1-nitropyrene (hereinafter abbreviated as 1-NP), 2-aminoanthracene (hereinafter abbreviated as 2-AA), and benzo [a] pyrene (hereinafter abbreviated as BaP) were used. The TA1535 luminescent vector transformant obtained in Example 2 was cultured overnight at 37 ° C. in a TGA medium. This culture solution was inoculated in a 1/50 volume in a TGA medium and cultured at 37 ° C. for 1.5 hours. This culture was diluted with TGA medium so that OD 600 = 0.1. 1.45 ml of this diluted culture solution
Aliquots into test tubes, each having a predetermined concentration of test sample 5
0 µl was added and the cells were cultured at 37 ° C for 2 hours. When a metabolic activator was required, 0.25 ml of the S9 mix and 50 μl of the test sample were added to 1.2 ml of the diluted culture, and the mixture was cultured at 37 ° C. for 2 hours.
【0037】培養後、菌液0.5mlを遠心し、沈澱画分
(菌体)に細胞溶解剤50μlを加え懸濁した。マイク
ロルミノリーダ用96穴プレートに、懸濁液10μl、
発光基質100μlを加え、発光量を発光測定装置(コ
ロナ製のマイクロルミノリーダ(MLR−100))で
測定した。また、培養液のOD600 を測定した。活性
(Intensity/OD600 )は、10秒間の発光
量を測定し、その値をOD600 の値で割ることにより求
めた。測定結果を図3〜5に示す。After the culture, 0.5 ml of the bacterial solution was centrifuged, and 50 μl of a cell lysing agent was added to the precipitated fraction (cells) and suspended. In a 96-well plate for microluminoreader, 10 μl of the suspension was added.
100 μl of a luminescent substrate was added, and the amount of luminescence was measured with a luminescence measuring device (Microlumino Reader (MLR-100) manufactured by Corona). Further, the OD 600 of the culture solution was measured. The activity (Intensity / OD 600 ) was determined by measuring the amount of luminescence for 10 seconds and dividing the value by the value of OD 600 . The measurement results are shown in FIGS.
【0038】比較例3 TA1535/pSK1002を、TGA培地で一夜3
7℃で培養した。この培養液をTGA培地に1/50容
量植菌し、37℃で1.5時間培養した。この培養液を
OD 600=0.1になるようにTGA培地で希釈した。
この希釈培養液を1.45mlずつ試験管に分注し、それ
ぞれに所定濃度の被験試料50μlを加え37℃で2時
間培養した。代謝活性化酵素を必要とする場合は、希釈
培養液1.2mlにS9ミックス0.25ml、被験試料5
0μlを加え、37℃で2時間培養した。この菌液のO
D600 を測定した。 Comparative Example 3 TA1535 / pSK1002 was added to a TGA medium for 3 nights.
The cells were cultured at 7 ° C. This culture solution was inoculated in a 1/50 volume in a TGA medium and cultured at 37 ° C. for 1.5 hours. This culture was diluted with TGA medium so that OD 600 = 0.1.
1.45 ml of the diluted culture solution was dispensed into test tubes, and 50 μl of a test sample having a predetermined concentration was added to each, and the mixture was cultured at 37 ° C. for 2 hours. When a metabolic activating enzyme is required, 0.25 ml of S9 mix and 1.2 ml of test sample
0 μl was added, and the cells were cultured at 37 ° C. for 2 hours. O of this bacterial solution
D600 was measured.
【0039】残りの菌液0.1mlに、Z−Buffer
0.9ml,0.1%SDS 50μl、クロロホルム1
0μlを加え、5秒間撹拌した。次に、0.1Mリン酸
緩衝液(pH7.0)に溶解した4mg/mlONPG水溶液
を0.2ml加え、28℃で10分間反応させた後、1 m
ol/1炭酸ナトリウム溶液を0.5ml加え反応を停止し
た。そして、直ちに420nm,550nmにおける吸光度
を測定した。活性(unit)は、ミラー法に基づき下
式により求めた。In the remaining 0.1 ml of the bacterial solution, add Z-Buffer
0.9 ml, 50% of 0.1% SDS, chloroform 1
0 μl was added and stirred for 5 seconds. Next, 0.2 ml of a 4 mg / ml aqueous solution of ONPG dissolved in 0.1 M phosphate buffer (pH 7.0) was added, and reacted at 28 ° C. for 10 minutes.
The reaction was terminated by adding 0.5 ml of an ol / 1 sodium carbonate solution. Then, the absorbance at 420 nm and 550 nm was measured immediately. The activity (unit) was determined by the following equation based on the Miller method.
【0040】[0040]
【数1】 図3および5が示すように本発明の発光測定法を用いた
場合、各被験試料共に従来の比色検出に比べ、測定のダ
イナミックレンジが数倍広がった。(Equation 1) As shown in FIGS. 3 and 5, when the luminescence measurement method of the present invention was used, the dynamic range of the measurement of each test sample was several times wider than that of the conventional colorimetric detection.
【0041】図4および5並びに表1が示すように本発
明の発光測定法を用いた場合、各被験試料共に従来の比
色検出に比べ、最少検出濃度が少なくとも4倍程度低濃
度になった。特にニトロアレーン(1−NP)、多環芳
香族化合物(BaP)については、最少検出濃度が約1
0倍低濃度になった。以下に示す実施例は、本発明の測
定のダイナミックレンジの拡大、最少検出濃度の低下と
いった高感度検出の機構を明らかにするために実施し
た。As shown in FIGS. 4 and 5 and Table 1, when the luminescence measurement method of the present invention was used, the minimum detection concentration of each test sample was at least about four times lower than the conventional colorimetric detection. . In particular, for nitroarenes (1-NP) and polycyclic aromatic compounds (BaP), the minimum detection concentration is about 1
The concentration became 0 times lower. The examples described below were carried out in order to clarify the mechanism of high-sensitivity detection, such as expansion of the dynamic range of the measurement of the present invention and reduction of the minimum detection concentration.
【0042】実施例4 マイクロルミノリーダ用96穴プレートに、細胞溶解剤
10μlに溶解した所定量のルシフェラーゼおよび発光
基質100μlを加え、10秒間の発光量を求めた。横
軸に酵素量(ルシフェラーゼ量)を、縦軸に対応する活
性(発光量)をそれぞれプロットし、図6に示した。 Example 4 A predetermined amount of luciferase dissolved in 10 μl of a cell lysing agent and 100 μl of a luminescent substrate were added to a 96-well plate for a microlumino reader, and the amount of luminescence for 10 seconds was determined. The enzyme amount (luciferase amount) is plotted on the horizontal axis, and the corresponding activity (light emission amount) is plotted on the vertical axis, and the results are shown in FIG.
【0043】水0.1mlに溶解した所定量のβ−ガラク
トシダーゼに、Z−Buffer0.9ml,0.1%S
DS50μl、およびクロロホルム10μlを加え、5
秒間撹拌した。次に、0.1Mリン酸緩衝液(pH7.
0)に溶解した4mg/mlONPG水溶液を0.2ml加
え、28℃で10分間反応させた後、1 mol/1炭酸ナ
トリウム溶液を0.5ml加え反応を停止した。そして、
直ちに420nmにおける吸光度を測定した。β−ガラク
トシダーゼ活性(unit)は、下式により求めた。To a predetermined amount of β-galactosidase dissolved in 0.1 ml of water, 0.9 ml of Z-Buffer, 0.1% S
50 μl of DS and 10 μl of chloroform were added, and 5
Stirred for seconds. Next, a 0.1 M phosphate buffer (pH 7.
0.2 ml of a 4 mg / ml aqueous solution of ONPG dissolved in 0) was added and reacted at 28 ° C. for 10 minutes, and 0.5 ml of a 1 mol / 1 sodium carbonate solution was added to stop the reaction. And
Immediately, the absorbance at 420 nm was measured. β-galactosidase activity (unit) was determined by the following equation.
【0044】活性=1000xOD420 横軸に酵素量(β−ガラクトシダーゼ量)を、縦軸に対
応する活性(β−ガラクトシダーゼ活性)をそれぞれプ
ロットし、図6に示した。また、実施例3、比較例3、
図6より各濃度のAF−2添加時に誘導されるルシフェ
ラーゼおよびβ−ガラクトシダーゼの酵素量を求め、図
7に示した。図6および7の結果から本発明における高
感度検出が可能となった理由を以下の如く推察した。Activity = 1000 × OD 420 The enzyme amount (β-galactosidase amount) is plotted on the horizontal axis, and the corresponding activity (β-galactosidase activity) is plotted on the vertical axis, and is shown in FIG. Further, Example 3, Comparative Example 3,
The amounts of luciferase and β-galactosidase induced when each concentration of AF-2 was added were determined from FIG. 6 and are shown in FIG. From the results of FIGS. 6 and 7, the reason why high-sensitivity detection in the present invention became possible was inferred as follows.
【0045】β−ガラクトシダーゼに比べ、ルシフェラ
ーゼの発現効率は全体的に低く、被験試料無添加時に
は、後者は前者の約1/106 しか発現していない。す
なわち、β−ガラクトシダーゼは、被験試料無添加時に
も多量合成されていることになる。この影響を受けるた
めと考えられるが、被験試料の添加によるβ−ガラクト
シダーゼの誘導合成のレスポンスは遅く、また、誘導合
成される量の誘導によらない合成量に対する相対的な割
合は小さくなっている。The expression efficiency of luciferase is generally lower than that of β-galactosidase, and when no test sample is added, the latter expresses only about 1/10 6 of the former. That is, a large amount of β-galactosidase is synthesized even when no test sample is added. This is thought to be due to the influence, but the response of the induction synthesis of β-galactosidase by the addition of the test sample is slow, and the relative ratio of the amount of the induced synthesis to the amount of the synthesis not induced is small. .
【0046】一方、被験試料の添加によるルシフェラー
ゼ誘導合成のレスポンスは速く、また、誘導合成される
量の誘導によらない合成量に対する相対的な割合は大き
くなっている。ルシフェラーゼ遺伝子の被験試料添加に
よる誘導合成のレスポンスの速さは、最少検出濃度が低
くなることを意味しており、また、誘導合成される量の
誘導によらない合成量に対する相対的割合の大きさは、
測定のダイナミックレンジが増大することを意味してい
る。On the other hand, the response of the luciferase-induced synthesis by the addition of the test sample is fast, and the relative ratio of the amount of the induced synthesis to the synthesis amount independent of the induction is large. The speed of response of induction synthesis by the addition of a test sample of the luciferase gene means that the minimum detection concentration is low, and the magnitude of the relative ratio of the amount of induction synthesis to the amount of synthesis not dependent on induction is high. Is
This means that the dynamic range of the measurement is increased.
【0047】このように、これらの現象および発明の効
果は、宿主サルモネラ菌TA1535内におけるβ−ガ
ラクトシダーゼ遺伝子とルシフェラーゼ遺伝子の発現効
率の差によってもたらされているもので、今回の詳細な
研究の結果新しく見い出されたものである。また、発現
効率が低いことは、従来の比色検出では検出の難しいこ
とを意味しており、ルシフェラーゼによる高感度な発光
検出を用いたことの特長が本発明の効果を生んだことを
示している。As described above, these phenomena and the effects of the present invention are brought about by the difference in expression efficiency between the β-galactosidase gene and the luciferase gene in the host Salmonella TA1535. It has been found. In addition, low expression efficiency means that it is difficult to detect with conventional colorimetric detection, indicating that the features of using high-sensitivity luminescence detection with luciferase produced the effects of the present invention. I have.
【0048】[0048]
【表1】 [Table 1]
【図1】実施例1及び比較例1で得られた発光測定、従
来法(比色法)による結果を示す。FIG. 1 shows the results of luminescence measurement and the conventional method (colorimetric method) obtained in Example 1 and Comparative Example 1.
【図2】実施例2及び比較例2で得られた発光測定、従
来法(比色法)による結果を示すグラフである。FIG. 2 is a graph showing the results of luminescence measurement and a conventional method (colorimetric method) obtained in Example 2 and Comparative Example 2.
【図3】実施例3および比較例3で得られた各々の被験
試料の各濃度でのレスポンスを被験試料を含まない条件
でのレスポンスで割った値(Ratio)→Ratio
(0〜20)を被験試料濃度に対してプロットした図で
ある。FIG. 3 shows the value obtained by dividing the response at each concentration of each test sample obtained in Example 3 and Comparative Example 3 by the response under the condition not including the test sample (Ratio) → Ratio
It is the figure which plotted (0-20) with respect to a test sample concentration.
【図4】実施例3および比較例3で得られた各々の被験
試料の各濃度でのレスポンスを被験試料を含まない条件
でのレスポンスで割った値(Ratio)→Ratio
(0〜10)を被験試料濃度に対してプロットした図で
ある。FIG. 4 is a value obtained by dividing the response at each concentration of each test sample obtained in Example 3 and Comparative Example 3 by the response under conditions not including the test sample (Ratio) → Ratio
It is the figure which plotted (0-10) with respect to a test sample concentration.
【図5】実施例3および比較例3で得られた各々の被験
試料の各濃度でのレスポンスを被験試料を含まない条件
でのレスポンスで割った値(Ratio)→Ratio
(0〜10)を被験試料濃度に対してプロットした図で
ある。FIG. 5 shows a value obtained by dividing the response at each concentration of each test sample obtained in Example 3 and Comparative Example 3 by the response under the condition not including the test sample (Ratio) → Ratio
It is the figure which plotted (0-10) with respect to a test sample concentration.
【図6】実施例4で得られたルシフェラーゼおよびβ−
ガラクトシダーゼの酵素量と活性の関係を示す検量線の
図である。FIG. 6 shows luciferase obtained in Example 4 and β-
FIG. 4 is a diagram of a calibration curve showing the relationship between the amount of galactosidase enzyme and activity.
【図7】実施例4で得られた検量線を用い、実施例3お
よび比較例3において各濃度のAF−2添加時に誘導さ
れたルシフェラーゼおよびβ−ガラクトシダーゼの酵素
量を算出し、AF−2濃度に対してプロットした図であ
る。FIG. 7: Using the calibration curves obtained in Example 4, the amounts of luciferase and β-galactosidase induced when each concentration of AF-2 was added in Example 3 and Comparative Example 3 were calculated. It is the figure plotted with respect to density.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI C12R 1:42) C12N 15/00 A (56)参考文献 特公 平4−12118(JP,B2) 社団法人日本生化学会編「新生化学実 験講座14 発生・分化・老化」株式会社 東京化学法人,p.322−3 (58)調査した分野(Int.Cl.7,DB名) C12N 15/00 - 15/70 BIOSIS(DIALOG)──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 7 Identification code FI C12R 1:42) C12N 15/00 A (56) References JP-B-4-12118 (JP, B2) Edited by The Biochemical Society of Japan “New Chemistry Laboratory Lecture 14 Development, Differentiation, and Aging” Tokyo Chemical Industry Co., Ltd., p. 322-3 (58) Field surveyed (Int. Cl. 7 , DB name) C12N 15/00-15/70 BIOSIS (DIALOG)
Claims (2)
伝子の下流に配置されたルシフェラーゼ活性を発現する
遺伝子を含んでなる組換遺伝子により形質転換されたサ
ルモネラ菌。1. A SOS gene expressed at the time of DNA damage, and a SOS gene transformed downstream from the recombinant gene comprising a gene expressing luciferase activity arranged downstream of the SOS gene.
Lumonella .
試料を含有する培地中で培養し、次に前記ルシフェラー
ゼ活性を発現する遺伝子群の発現による発光を測定す
る、ことを特徴とする被験試料中の変異原性物質の存否
の決定又は存在量の測定を行なうための方法。2. A test sample, wherein the Salmonella according to claim 1 is cultured in a medium containing the test sample, and then luminescence due to expression of the genes expressing the luciferase activity is measured. A method for determining the presence or absence of a mutagenic substance in a substance or measuring the abundance.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22965994A JP3277436B2 (en) | 1993-10-22 | 1994-09-26 | Mutagen detection method using luminescent gene |
US08/326,949 US5702883A (en) | 1993-10-22 | 1994-10-21 | Methods for detection of mutagens using luminescence gene |
EP94307739A EP0649905B1 (en) | 1993-10-22 | 1994-10-21 | Methods of detection of mutagens using luminescence gene |
DE69413491T DE69413491T2 (en) | 1993-10-22 | 1994-10-21 | Method for the detection of mutagens using a luminescent gene |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5-264894 | 1993-10-22 | ||
JP26489493 | 1993-10-22 | ||
JP22965994A JP3277436B2 (en) | 1993-10-22 | 1994-09-26 | Mutagen detection method using luminescent gene |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07163359A JPH07163359A (en) | 1995-06-27 |
JP3277436B2 true JP3277436B2 (en) | 2002-04-22 |
Family
ID=26528928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22965994A Expired - Fee Related JP3277436B2 (en) | 1993-10-22 | 1994-09-26 | Mutagen detection method using luminescent gene |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3277436B2 (en) |
-
1994
- 1994-09-26 JP JP22965994A patent/JP3277436B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
社団法人日本生化学会編「新生化学実験講座14 発生・分化・老化」株式会社東京化学法人,p.322−3 |
Also Published As
Publication number | Publication date |
---|---|
JPH07163359A (en) | 1995-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pinner et al. | Physiological role of nhaB, a specific Na+/H+ antiporter in Escherichia coli. | |
Longtine et al. | Additional modules for versatile and economical PCR‐based gene deletion and modification in Saccharomyces cerevisiae | |
Stansfield et al. | Missense translation errors in Saccharomyces cerevisiae | |
Wanner et al. | Regulation of lac operon expression: reappraisal of the theory of catabolite repression | |
Hentschel et al. | Destabilized eYFP variants for dynamic gene expression studies in C orynebacterium glutamicum | |
US20070020715A1 (en) | Novel fluorogenic substrates for beta-lactamase gene expression | |
EP0649905B1 (en) | Methods of detection of mutagens using luminescence gene | |
TW200846469A (en) | Secreted MLuc7 luciferase and use thereof | |
US20050181469A1 (en) | Beta-lactamase substrates having phenolic ethers | |
Rosen et al. | Microbial sensors of ultraviolet radiation based on recA’:: lux fusions | |
Qi et al. | Methods to study antagonistic activities among oral bacteria | |
Tian et al. | Explanation for different types of regulation of arginine biosynthesis in Escherichia coli B and Escherichia coli K12 caused by a difference between their arginine repressors | |
CN116555204B (en) | Mutant luciferase with improved performance and application thereof | |
JP3277436B2 (en) | Mutagen detection method using luminescent gene | |
Omote et al. | The alpha/beta subunit interaction in H (+)-ATPase (ATP synthase). An Escherichia coli alpha subunit mutation (Arg-alpha 296–> Cys) restores coupling efficiency to the deleterious beta subunit mutant (Ser-beta 174–> Phe). | |
Miller et al. | Degradation of Escherichia coli beta-galactosidase fragments in protease-deficient mutants of Salmonella typhimurium | |
JP4272265B2 (en) | Diagnostic system and method for determining the presence of genotoxic compounds in a sample | |
AU2002251755A1 (en) | Beta-lactamase substrates having phenolic ethers | |
JP2008113620A (en) | Luminescence method for luciferase | |
Gonzalez et al. | Structural insights into the regulation of SOS mutagenesis | |
JP3277426B2 (en) | Reagent-free mutagen detection method | |
Salehi-Sedeh et al. | Effect of mutation at positively charged residues (K329 and R330) in a flexible region of firefly luciferase on structure and kinetic properties | |
Qi et al. | Methods to Study Antagonistic Activities Among Oral Bacteria | |
Štagoj et al. | The GAL induction response in yeasts with impaired galactokinase Gal1p activity | |
JP2000189162A (en) | Mutagen-detection and transformed body used therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |